FineMark National Bank & Trust Grows Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

FineMark National Bank & Trust boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 21,378 shares of the medical equipment provider’s stock after acquiring an additional 316 shares during the quarter. FineMark National Bank & Trust’s holdings in Intuitive Surgical were worth $11,158,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of ISRG. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical during the fourth quarter valued at approximately $82,517,000. Sycomore Asset Management raised its position in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after acquiring an additional 4,079 shares during the period. Exome Asset Management LLC boosted its stake in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. grew its position in shares of Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after acquiring an additional 525 shares during the period. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of recent research reports. Bernstein Bank raised their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. UBS Group raised their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Leerink Partners boosted their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, Evercore ISI lifted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 over the last 90 days. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $508.58 on Tuesday. The stock has a 50 day moving average price of $561.62 and a 200-day moving average price of $532.25. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company has a market capitalization of $181.15 billion, a P/E ratio of 79.34, a P/E/G ratio of 5.85 and a beta of 1.43.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.